Skip to main content
. 2014 Jan 17;28(3):395–405. doi: 10.1210/me.2013-1404

Figure 5.

Figure 5.

Effect of metabolic inhibitors on SRC-1 protein levels. a, A549 cells were grown in the absence or presence of glucose. Cells grown under glucose-containing medium were then treated with rotenone, oligomycin A, or 2-deoxyglucose (2-DG) at different concentrations. b, A549 cells grown in glucose-containing medium were treated with rotenone, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), or combinations of both compounds as indicated. c, A549 cells grown in glucose-containing medium were treated with NAM or FK866 at the indicated concentration. d, PC-3 cells were grown in glucose-containing medium and treated with rotenone, oligomycin A, or 2-DG at the indicated. e, PC-3 cells grown in glucose-containing medium were treated with NAM at the indicated concentrations. For all treatments described, whole-cell lysates were then subjected to immunoblot analysis for the indicated proteins. f, NADH measurement of A549 cells grown in the absence or presence of glucose.